Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-25

FDA Approved: VIZAMYL — Original Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))

View source ↗

Summary

FDA approved Vizamyl (flutemetamol F-18) under an original application as a PET imaging agent to detect beta-amyloid plaques in adult patients being evaluated f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIZAMYL (Flutemetamol F-18)

Snippet

ORIG AP for VIZAMYL (FLUTEMETAMOL F-18)